Zopicon 7.5mg (Zopiclone Tablets IP)

Zopicon 7.5 mg contains zopiclone, a non-benzodiazepine hypnotic from the cyclopyrrolone class. Unlike longer-acting sleep medications, zopiclone acts quickly and is primarily intended for short-term treatment of insomnia.

• Helps reduce sleep latency (time to fall asleep).

• Supports continuous sleep throughout the night.

• Minimizes next-day drowsiness when taken appropriately.

The 7.5 mg dose is the standard adult dose and is best used as part of a short-term treatment plan, often complemented with good sleep hygiene practices such as regular sleep schedules and reduced screen exposure before bed.

• Rapid sleep induction – Shortens the time it takes to fall asleep.

• Improved sleep quality – Supports uninterrupted, restful sleep.

• Short-term insomnia relief – Effective for temporary sleep disturbances caused by stress or lifestyle factors.

• Minimal morning grogginess – Designed for quick-acting effect with limited residual sedation.

• Convenient oral tablet – Easy to take before bedtime.

• Take one 7.5 mg tablet orally immediately before bedtime.

• Swallow the tablet whole with water; do not crush or split unless instructed.

• Avoid alcohol and other sedatives while using Zopicon, as these can enhance drowsiness.

• Generally prescribed for short-term use (2–4 weeks) unless otherwise directed.

• Combine with healthy sleep habits for maximum effectiveness.

Always follow your healthcare provider’s instructions for dosage and duration of use.

• Common side effects: Drowsiness, dizziness, dry mouth, mild headache.

• Avoid driving or operating machinery until you know how the medication affects you.

• Inform your healthcare provider of any liver, kidney, or respiratory conditions.

• Do not use if allergic to zopiclone or similar hypnotic agents.

• Risk of dependence – Use only as prescribed and for the recommended duration.

• Seek medical attention if you experience sleepwalking, unusual behaviors, or severe reactions.

Short-term use is recommended to reduce the risk of tolerance, dependence, or withdrawal symptoms.